Liver involvement in pediatric celiac disease
Caterina Anania1, Ester De Luca1, Giovanna De Castro1
1Caterina Anania, Ester De Luca, Giovanna De Castro, Lucia Pacifico, Department of Pediatrics and Child Neuropsychiatry, Sapienza University of Rome, Rome, Viale Regina Elena, 324 00161 Rome, Italy.
Celiac disease (CD), an immune disorder triggered by gluten, can affect the liver. This review explores CD-related liver issues in children, aiding diagnosis and treatment.
Area of Science:
- Gastroenterology
- Hepatology
- Pediatrics
Background:
- Celiac disease (CD) is an intestinal inflammatory disorder affecting genetically susceptible individuals upon gluten exposure.
- It is a prevalent chronic condition, impacting approximately 1% of the population in Europe and North America.
- While primarily affecting the gut, CD can manifest with varied clinical presentations, including extraintestinal manifestations like liver involvement.
Purpose of the Study:
- To review the clinical presentations of liver injury associated with celiac disease.
- To explore the potential mechanisms underlying CD-related hepatic dysfunction.
- To identify strategies for diagnosing and treating these liver disorders in children.
Main Methods:
- Literature review of clinical presentations of celiac disease-related liver injury.
- Analysis of proposed mechanisms for CD-associated hepatic manifestations.
- Synthesis of diagnostic and therapeutic approaches for pediatric cases.
Main Results:
- Hepatic dysfunction in CD ranges from asymptomatic elevations in liver enzymes to chronic liver disease.
- Nonspecific reactive hepatitis and cryptogenic liver disorders are observed in some CD patients.
- The review consolidates information on the spectrum of liver involvement in CD.
Conclusions:
- Celiac disease can present with diverse hepatic manifestations, extending beyond gastrointestinal symptoms.
- Understanding the mechanisms of CD-related liver injury is crucial for effective management.
- Early diagnosis and appropriate treatment strategies are essential for improving outcomes in children with CD-associated liver disease.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption


